2022
June
29,
2022
|
14:00 PM
Europe/Amsterdam
Establishment of new precision molecular oncology research center to drive development of novel targeted cancer therapies for patients with unmet medical need / Strategic investment of $140M USD to expand presence in leading center of biotech innovat...
Read more
March
22,
2022
|
12:30 PM
Europe/Amsterdam
Co-founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D., and Vida Ventures along with serial entrepreneurs Arjun Goyal, M.D., M.Phil., and Jak Knowles, M.D./ Foundational cell therapy...
Read more
2021
December
01,
2021
|
14:00 PM
Europe/Amsterdam
The Consumer Health division accelerates the execution of its sustainability program and strikes partnership for collective action across the self care industry...
Read more
September
22,
2021
|
09:00 AM
Europe/Amsterdam
Initial product offering will focus on key crops for greenhouse and glasshouse markets: tomato, sweet pepper and cucumber / Commercial launch is slated for 2022 in Canada, US, Mexico, Spain and Italy with potential for future expansion...
Read more
July
29,
2021
|
15:00 PM
Europe/Amsterdam
Leverkusen, July 29, 2021 - Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspe...
Read more
May
27,
2021
|
01:07 AM
Europe/Amsterdam
Leverkusen, May 27, 2021 - Bayer announced today a series of actions it plans to implement following the denial of the motion to preliminarily approve the Roundup™ class settlement agreement, designed to address potential future litigation, by Judge ...
Read more
February
03,
2021
|
18:00 PM
Europe/Amsterdam
Motion for preliminary approval is being filed for program designed to manage and resolve future Roundup™ litigation...
Read more
February
02,
2021
|
14:00 PM
Europe/Amsterdam
Primary Focus will be on Most Vulnerable - Pregnant Women and Children in Underserved Communities...
Read more
2020
December
07,
2020
|
05:00 AM
Europe/Amsterdam
Agreement is fundamental element of Bayer’s new Cell & Gene Therapy strategy / Bayer to enter CAR-T cell therapy space and expand oncology development pipeline with groundbreaking technology / Recognizes the leading position of Atara’s technology pla...
Read more
August
20,
2020
|
19:00 PM
Europe/Amsterdam
Leverkusen, August 20, 2020 - Bayer announced today that it has reached agreements with plaintiff law firms to resolve approximately 90% of the nearly 39,000 total filed and unfiled U.S. Essure™ claims involving women who allege device-related injuri...
Read more
August
12,
2020
|
10:00 AM
Europe/Amsterdam
Initial efforts will focus on innovating vegetable varieties that deliver optimized quality and sensory experience / Called Unfold, the new company will be headquartered in the Davis, Calif., area with key operations in both the U.S. and Singapore / ...
Read more
July
08,
2020
|
15:00 PM
Europe/Amsterdam
Leverkusen, July 8, 2020 - Bayer announced today that it is in agreement with counsel representing the proposed Roundup settlement class on their decision to withdraw the pending motion for preliminary approval of the parties’ issue class agreement. ...
Read more
July
08,
2020
|
15:00 PM
Europe/Amsterdam
Leverkusen, July 8, 2020 - Bayer announced today that it is in agreement with counsel representing the proposed Roundup settlement class on their decision to withdraw the pending motion for preliminary approval of the parties’ issue class agreement. ...
Read more
June
24,
2020
|
21:00 PM
Europe/Amsterdam
Company will make a total payment of $10.1 billion to $10.9 billion (EUR 9.1 billion to EUR 9.8 billion) to resolve current and address potential future Roundup™ litigation / Company also resolves dicamba drift litigation for payment of up to $400 mi...
Read more
April
21,
2020
|
14:30 PM
Europe/Amsterdam
Investigation of combination therapies including Bayer’s chloroquine and interferon beta-1b to foster much needed solutions for patients in fight against coronavirus pandemic / Bayer Canada to make CAD 1.5 million (approximately 1 million euros) fina...
Read more
January
31,
2020
|
13:00 PM
Europe/Amsterdam
"Decision of EPA corresponds to the long-standing assessments of leading international health authorities", says Liam Condon, Bayer Board Member / The Amicus brief of the U.S. Department of Justice in the Hardeman case also support Glyphosate´s safet...
Read more
2019
September
02,
2019
|
11:00 AM
Europe/Amsterdam
Divestiture enables Bayer to focus on core OTC business...
Read more
May
13,
2019
|
19:00 PM
Europe/Amsterdam
Significant expansion of portfolio will advance Beiersdorf’s leading position as sun care expert / Beiersdorf delivers first major acquisition under its new C.A.R.E.+ strategy / Divestiture enables Bayer to focus on core OTC business...
Read more
2018
October
12,
2018
|
09:00 AM
Europe/Amsterdam
Xarelto, in combination with aspirin, is indicated to reduce the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease / Xarelto, in combination with aspirin, is the only non-vitamin K antag...
Read more
August
30,
2018
|
13:00 PM
Europe/Amsterdam
Jivi’s extended half-life allows for twice-weekly initial dosing / May be adjusted to every five days and further individually adjusted to less or more frequent dosing...
Read more
2017
September
14,
2017
|
23:00 PM
Europe/Amsterdam
Accelerated approval based on overall response rate (ORR) of 104 adult patients with relapsed follicular lymphoma (FL) from the Phase II CHRONOS-1 study / Continued approval for this indication may be contingent upon verification and description of c...
Read more
